Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1UB-312----[1] 6 💬
2UB-312 Injection----[2] 6, 17 💬
3UB-VV410----[1] 49 💬
4Ubenimex[1] Ubenimex[1] Ubenimex 💬 [1] ANPEP 💬 [4] Glutathione metabolism, Hematopoietic cell lineage, Phagocytosis, Renin-angiotensin system 💬[1] 86 💬
5Ubidecarenon----[2] 5, 6 💬
6Ubiquinol[1] Ubiquinol---[4] 6, 8, 17, 57 💬
7UBLITUXIMAB[1] Ublituximab[1] Ublituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
8Ubltuximab----[1] 13 💬
9Ubrogepant[1] Ubrogepant[1] Ubrogepant 💬 [1] CALCRL 💬 [2] Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬[1] 226 💬
10UC-MSC+DMARDS----[1] 46 💬
11UC-MSCs----[1] 46 💬
12UCAR T-cell----[7] 11, 13, 14, 49, 51, 66, 222 💬
13UCAR T-cell group----[3] 11, 49, 61 💬
14UCAR-T cells----[2] 49, 51 💬
15Ucb 34714----[1] 309 💬
16Ucb L059----[1] 13 💬
17UCB0022----[1] 6 💬
18UCB0107 (bepranemab)[1] Bepranemab[1] Bepranemab 💬 [1] MAPT 💬 [4] Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[1] 5 💬
19UCB0599----[1] 6 💬
20UCB3491----[1] 145 💬
21UCB4940----[3] 46, 97, 271 💬
22UCB5857----[1] 53 💬
23UCB7665[1] Rozanolixizumab[1] Rozanolixizumab 💬 --[3] 11, 14, 63 💬
24UCB7853----[1] 6 💬
25UCMSC----[3] 51, 57, 94 💬
26UCMSC group----[1] 97 💬
27UDCA----[2] 93, 94 💬
28UDCA (Ursodeoxycholic acid)[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
29Udenafil[1] Udenafil[1] Udenafil 💬 [1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[2] 86, 210 💬
30UF-021----[1] 90 💬
31UK 092480----[1] 86 💬
32UK-427,857----[1] 46 💬
33UK-92,480----[1] 86 💬
34UK-92,480-10----[1] 86 💬
35UK: Sativex Oromucosal Spray----[1] 13 💬
36ULARITIDE[1] Ularitide---[1] 86 💬
37Ulefnersen[1] Ulefnersen---[1] 2 💬
38Ulinastatin[1] Ulinastatin[1] Ulinastatin 💬 [6] CTRB1,
CTRB2,
ELANE,
PRSS1,
PRSS2,
PRSS3 💬 		[8] Influenza A, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pancreatic secretion, Phagocytosis, Protein digestion and absorption, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬[1] 70 💬
39Ulipristal[1] Ulipristal[2] Ulipristal ,
Ulipristal acetate 💬 		[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 10 💬
40ULIPRISTAL ACETATE[2] Acetate,
Ulipristal		[2] Ulipristal ,
Ulipristal acetate 💬 		[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 10 💬
41ULSC----[1] 113 💬
42ULSC (1.5 x 10^8 cells/dose)----[1] 50 💬
43Ultevursen[1] Ultevursen---[2] 90, 303 💬
44Ultomiris----[7] 2, 11, 13, 50, 62, 66, 109 💬
45ULTOMIRIS - 300 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 3 ML (100 MG / ML) - 1 FLACONCINO----[1] 62 💬
46Ultomiris 1,100 mg/11 mL----[1] 11 💬
47Ultomiris 300 mg/30 ml----[1] 66 💬
48Ultomiris 300mg/30ml----[1] 62 💬
49ULTOMIRIS ™ (ravulizumab-cwvz)[1] Ravulizumab[1] Ravulizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
50ULTOMIRIS®----[1] 13 💬
51Ultra small particles of iron oxide (USPIO)----[1] 13 💬
52Ultra-high-caloric carbohydrate-rich diet----[1] 2 💬
53Ultra-high-caloric fatty diet----[1] 2 💬
54Ultracet----[1] 271 💬
55Ultrase® MT12----[1] 299 💬
56Ultrase® MT20----[1] 299 💬
57Ultrasmall particles of iron oxide----[1] 13 💬
58Ultrasound----[1] 171 💬
59Ultrasound Elastography----[1] 96 💬
60Ultrasound Imaging----[2] 34, 96 💬
61Ultrasound Microbubble Contrast Agent----[1] 96 💬
62Ultrasound Vascularity----[1] 96 💬
63Ultrasound-guided Suprascapular Nerve Block----[1] 149 💬
64ULTRESA----[1] 299 💬
65Ultromiris----[1] 13 💬
66Ulviprubart[1] Ulviprubart[1] Ulviprubart 💬 --[1] 15 💬
67Ulviprubart (ABC008)[1] Ulviprubart[1] Ulviprubart 💬 --[1] 15 💬
68Umbilical cord blood----[2] 2, 60 💬
69Umbilical Cord Blood After Myeloablative Conditioning----[1] 60 💬
70Umbilical Cord Blood After Reduced-Intensity Conditioning----[1] 60 💬
71Umbilical cord blood CD19-BCMA CAR-T cells infusion----[2] 51, 53 💬
72Umbilical cord blood mononuclear cells----[1] 97 💬
73Umbilical cord blood therapy----[2] 2, 6 💬
74Umbilical Cord Blood Transplantation----[5] 60, 65, 284, 285, 326 💬
75Umbilical Cord Blood Unit----[1] 333 💬
76Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation----[2] 93, 296 💬
77Umbilical cord derived Mesenchymal Stem Cells----[1] 13 💬
78Umbilical Cord Lining Stem Cells----[1] 50 💬
79Umbilical cord mesenchymal stem cell----[2] 18, 113 💬
80Umbilical Cord Mesenchymal Stem Cell (UC-MSC)----[1] 90 💬
81Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (High-Dose)[1] Mesenchymal Stem Cell-Derived Exosomes---[1] 127 💬
82Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (Low-Dose)[1] Mesenchymal Stem Cell-Derived Exosomes---[1] 127 💬
83Umbilical cord mesenchymal stem cells----[5] 13, 46, 57, 97, 113 💬
84Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)----[2] 46, 296 💬
85UN-ALPHA-R----[1] 235 💬
86UN-ALPHA-R 0.25µg----[1] 235 💬
87Unavailable----[1] 36 💬
88Uncommon nutrient supplementation----[1] 299 💬
89Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein)[1] Genistein[1] Genistein 💬 --[1] 299 💬
90Uncoupled RBCs----[1] 13 💬
91Undetermined----[2] 96, 97 💬
92UNDIFFERENTIATED AUTOLOGOUS MESENCHYMAL STEM CELLS----[1] 13 💬
93Uniplas----[1] 64 💬
94Universal allogeneic anti-CD19/BCMA CAR T-cells----[4] 11, 49, 51, 61 💬
95Universal anti-CD70 CAR-T (CHT101)----[1] 49 💬
96Universal BCMA CAR-T----[3] 11, 13, 14 💬
97Universal BCMA-CD19 CART----[1] 13 💬
98Universal CD19 CAR-?dT Cell Injection----[3] 11, 13, 14 💬
99Universal CD19 CAR-T----[3] 11, 13, 14 💬
100Universal STAR-T Cell----[1] 63 💬
101Universal STAR-T Cell Injection----[1] 13 💬
102University of Turin----[1] 48 💬
103UnK----[1] 77 💬
104Unknown----[3] 34, 67, 97 💬
105Unoprostone[1] Unoprostone[2] Isopropyl unoprostone ,
Unoprostone 💬 		[1] PTGFR 💬 [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬[1] 90 💬
106Unrelated donor bone marrow transplant----[1] 60 💬
107Unrelated Umbilical Cord Blood Transplant----[1] 19 💬
108Unstimulated saliva sampling----[1] 98 💬
109Untreated to atorvastatin treatment[1] Atorvastatin[2] Atorvastatin calcium ,
Atorvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 13 💬
110Upadacitinib[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[12] 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
111Upadacitinib (ABT-494)[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 53, 97 💬
112Upadacitinib - Direct compression-yellow[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
113Upadacitinib - Wet Granulation-Yellow[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
114Upadacitinib -Direct compression-yellow[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
115Upadacitinib 12mg[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
116Upadacitinib 15 MG[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
117Upadacitinib 15 MG [Rinvoq][1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
118Upadacitinib 15mg[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
119Upadacitinib 30mg[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
120Upadacitinib 30mg Dose[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 98 💬
121Upadacitinib 3mg[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
122Upadacitinib <15 MG [Rinvoq][1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
123Upadacitinib Extended Release Oral Tablet[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
124Upadacitinib Oral Product[1] Upadacitinib[3] Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[1] JAK1 💬 [27] Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
125Upadaticitib----[1] 96 💬
126Updacitinib (ABT-494)----[1] 97 💬
127Uplizna----[3] 11, 13, 300 💬
128UPLYSO----[1] 19 💬
129Upper limb muscle block----[1] 149 💬
130Uptravi----[3] 84, 86, 88 💬
131Uptravi® Film Coated Tablets----[1] 86 💬
132UR-12746-S----[1] 97 💬
133Urbason----[1] 97 💬
134Urbason 40 mg----[1] 13 💬
135URBASON 40 mg comprimidos----[1] 13 💬
136URBASON FORTE----[1] 13 💬
137Urbason solubile forte 1000mg----[1] 13 💬
138URBASON*IM EV 1F 250MG+1F 5ML----[2] 222, 223 💬
139Urbason® solubile forte 1000 mg----[1] 13 💬
140Urea[1] Urea[2] Urea ,
Urea C13 💬 		--[2] 72, 251 💬
141URG101----[1] 226 💬
142Uridine[1] Uridine---[1] 299 💬
143Urinary collect----[1] 299 💬
144Urinary levels of PIIINP as a marker of changes in renal function----[1] 299 💬
145Urine and blood samples----[1] 179 💬
146Urine collection----[1] 19 💬
147Urine sample----[5] 49, 51, 61, 63, 84 💬
148Urine samples----[1] 13 💬
149Urine samples collect----[1] 234 💬
150Urine samples taken to measure methotrexate and its major metabolite 7-OH-methotrexate level[1] Methotrexate[2] Methotrexate ,
Methotrexate sodium 💬 		[2] DHFR,
DHFR2 💬 		[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[1] 46 💬
151Urine sampling----[1] 98 💬
152Urine test----[1] 46 💬
153Urodilatin----[1] 86 💬
154Urodynamic study----[1] 226 💬
155UROMITEXAN----[1] 85 💬
156URSOCHOL 300----[1] 67 💬
157Ursodeoxycholic acid[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[10] 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 💬
158Ursodeoxycholic acid (UDCA)[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 94 💬
159Ursodeoxycholic acid (UDCA) 500 mg[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 46 💬
160Ursodeoxycholic Acid (URSO)[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
161Ursodeoxycholic Acid 300mg capsule[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
162Ursodeoxycholic Acid 300mg tablet[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
163Ursodeoxycholic Acid Capsules[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
164Ursodeoxycholic acid combination of immunosuppressive agents[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[2] 93, 95 💬
165Ursodeoxycholic acid combined with total glucosides of paeony[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
166Ursodeoxycholic acid only[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
167Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)[2] Methylprednisolone,
Ursodeoxycholic acid		[3] Methylprednisolone ,
Ursodiol ,
Methylprednisolone acetate 💬 		[2] NR1H4,
NR3C1 💬 		[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 93 💬
168Ursodeoxycholsäure----[1] 93 💬
169Ursodiol----[5] 8, 20, 93, 234, 299 💬
170Ursodiol (ursodeoxycholic acid, UDCA)[1] Ursodeoxycholic acid[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 97 💬
171Ursodoxicoltaurina----[1] 2 💬
172Ursodoxicoltaurine----[1] 2 💬
173Ursodoxycoltaurine----[1] 2 💬
174Ursofalk----[4] 93, 94, 96, 97 💬
175UrsoFalk® 250 mg tabletten.----[1] 96 💬
176Ursofalk® 500 mg film-coated tablets----[1] 93 💬
177Ursofalk® 500 mg Filmtabletten----[1] 93 💬
178Ursofalk® capsules----[1] 93 💬
179Ursolic acid[1] Ursolic acid---[1] 94 💬
180Ursonorm----[1] 6 💬
181US guided ESPB----[1] 70 💬
182US TAP Bupivacaine/Epinephrine[2] Bupivacaine,
Epinephrine		[5] Epinephrine ,
Epinephrine hydrochloride ,
Bupivacaine hydrochloride ,
Epinephrine bitartrate ,
Bupivacaine 💬 		[15] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[20] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 96, 97 💬
183US-licensed Humira®----[1] 46 💬
184US-Ocrevus----[1] 13 💬
185USAN: sebelipasa alfa----[1] 19 💬
186USAN: sebelipase alpha----[1] 19 💬
187Use of an Electronic Data Capture System by patients and physicians to assess patient-physician interactions & therapeutic decisions & outcomes in RA subjects.----[1] 46 💬
188Use of bioanalytical assay to monitor plasma levels of perhexiline[1] Perhexiline[2] Perhexiline maleate ,
Perhexiline 💬 		[8] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CPT1A,
CPT1B,
CPT1C,
CPT2 💬 		[47] AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Efferocytosis, Fatty acid degradation, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 58 💬
189Use of lipid-lowering drugs.----[1] 265 💬
190UshStat----[2] 90, 303 💬
191UshStat (SAR421869)[1] SAR421869---[2] 90, 303 💬
192Usnoflast[1] Usnoflast[1] Usnoflast 💬 [1] NLRP3 💬 [12] C-type lectin receptor signaling pathway, Coronavirus disease, Cytosolic DNA-sensing pathway, Influenza A, Lipid and atherosclerosis, NOD-like receptor signaling pathway, Necroptosis, Pathogenic Escherichia coli infection, Pertussis, Salmonella infection, Shigellosis, Yersinia infection 💬[1] 2 💬
193Ustekinumab[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
194Ustekinumab (6 mg/kg)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
195Ustekinumab (90 mg)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
196Ustekinumab (approximately 6 mg/kg)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 49, 96 💬
197Ustekinumab (UST)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
198Ustekinumab + MTX (Group 2)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 46 💬
199Ustekinumab + MTX (Group 3)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 46 💬
200Ustekinumab - Standard Dosage[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
201Ustekinumab 130 mg IV[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
202Ustekinumab 180 mg[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 93 💬
203Ustekinumab 1mg/kg (IP)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
204Ustekinumab 3 mg/kg (IP)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
205Ustekinumab 4.5 mg/kg[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
206Ustekinumab 45 mg[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 93, 96 💬
207Ustekinumab 6 mg/kg[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 50 💬
208Ustekinumab 6 mg/kg (IP)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
209Ustekinumab 90 mg[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[6] 49, 50, 56, 93, 96, 97 💬
210Ustekinumab 90 mg (SC) Group 1[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
211Ustekinumab 90 mg (SC) Group 2[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
212Ustekinumab 90 mg SC q12w[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
213Ustekinumab 90 mg SC q8w[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
214Ustekinumab 90 milligram (mg)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 49 💬
215Ustekinumab and semi enteral nutrition[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
216Ustekinumab and Upadacitinib[2] Upadacitinib,
Ustekinumab		[4] Ustekinumab ,
Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[4] IL12A,
IL12B,
IL23A,
JAK1 💬 		[43] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis 💬[1] 96 💬
217Ustekinumab approximately 6 mg/kg (IV)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
218Ustekinumab Dose Based on BSA and Body Weight[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 97 💬
219Ustekinumab Injection[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 160 💬
220Ustekinumab Injection [Stelara][1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
221Ustekinumab IV[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 49, 97 💬
222Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
223Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP)[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
224Ustekinumab IV Infusion[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
225Ustekinumab liquid in prefilled syringe[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 84 💬
226Ustekinumab SC[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 49, 97 💬
227Ustekinumab SC Injection[1] Ustekinumab[1] Ustekinumab 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
228Usual Care----[1] 86 💬
229Usual care medications----[1] 265 💬
230Usual current care----[2] 96, 97 💬
231Usual DMT continuation----[1] 13 💬
232Usual dopaminergic per os treatment----[1] 6 💬
233Usual treatment----[1] 85 💬
234UT-15 SR----[1] 51 💬
235UT-15C----[1] 86 💬
236UT-15C (treprostinil diethanolamine)[2] Diethanolamine,
Treprostinil		[4] Diethanolamine ,
Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
237UT-15C 0.25 mg----[1] 86 💬
238UT-15C 1 mg----[1] 86 💬
239UT-15C 5 mg----[1] 86 💬
240UT-15C LP----[1] 86 💬
241UT-15C SR----[2] 51, 86 💬
242UT-15C SR (treprostinil diethanolamine)[2] Diethanolamine,
Treprostinil		[4] Diethanolamine ,
Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
243UT-15C-SR----[2] 51, 86 💬
244UTAA91 injection----[3] 46, 49, 51 💬
245Utreloxastat[1] Utreloxastat[1] Utreloxastat 💬 [1] ALOX15 💬 [6] Arachidonic acid metabolism, Efferocytosis, Ferroptosis, Linoleic acid metabolism, Necroptosis, Serotonergic synapse 💬[1] 2 💬
246UTTR1147A----[2] 96, 97 💬
247UTTR1147A, IL22-Fc, IL-22Fc[1] Efmarodocokin alfa[1] Efmarodocokin alfa 💬 [1] IL22 💬 [4] Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬[2] 96, 97 💬
248UTTR1147A/RO7021610 (Active)----[2] 96, 97 💬
249UVADEX----[3] 46, 51, 96 💬
250UVADEX and UVAR XTS Photopheresis System----[1] 96 💬
251UVEDOSE----[2] 13, 46 💬
252UVEDOSE 100 000 UI----[1] 13 💬
253UVEDOSE 100 000 UI, solution buvable en ampoule----[1] 13 💬
254UVEDOSE 2,5mg (100000UI)----[1] 13 💬
255UVEDOSE 2.5mg (100 000 UI)----[1] 13 💬
256UX-DA001----[1] 6 💬
257UX001----[1] 30 💬
258UX003----[1] 19 💬
259UX007----[5] 8, 248, 256, 257, 344 💬
260UX053[1] UX053---[1] 257 💬
261UX111----[1] 19 💬
262UX143, BPS804----[1] 274 💬
263UX701[1] UX701---[1] 171 💬
264UX701 (1.0 × 10^13 genome copies/kg)[1] UX701---[1] 171 💬
265UX701 (2.0 × 10^13 genome copies/kg)[1] UX701---[1] 171 💬
266UX701 (5.0 × 10^12 genome copies/kg)[1] UX701---[1] 171 💬